--2024/Q4-- / 8.004B--
--2024/Q3-- / 8.405B--
Jul 31, 20242024/Q27.884B / 7.493B--
May 1, 20242024/Q17.363B / 7.060B--
--2023/Q48.052B / 7.621B--
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 42.630
- +0.680+1.62%
Close Aug 23 16:00 ET
- 42.630
- 0.0000.00%
Post 20:02 ET
86.94BMarket Cap16.68P/E (TTM)
42.640High42.120Low3.78MVolume42.270Open41.950Pre Close160.87MTurnover0.19%Turnover Ratio13.58P/E (Static)2.04BShares45.36852wk High4.62P/B84.16BFloat Cap32.42252wk Low1.48Dividend TTM1.97BShs Float45.368Historical High3.48%Div YieldTTM1.24%Amplitude6.447Historical Low42.552Avg Price1Lot Size
GlaxoSmithKline Key Stats
GlaxoSmithKline Q2 2024 Earnings Date
Currency：GBPJul 31, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 7.49B | 7.88B | +390.53M |
| Beat Est. | +4.40% | +9.84% | +5.21% |
| EPS | 0.70 | 0.57 | -0.13 |
| Miss Est. | -14.77% | -10.26% | -18.12% |
Analyst Rating
Aug 7, 2024
GlaxoSmithKline Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: GBP
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GlaxoSmithKline Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
